Association of human leucocyte antigen class I (HLA-A and HLA-B) with chronic hepatitis C virus infection in egyptian patients

Scandinavian Journal of Immunology

Volumn 72, Issue 6, 2010, Pages 548-553

  Mosaad, Y M ^a   Farag, R E ^a   Arafa, M M ^a   Eletreby, S ^a   El Alfy, H A ^a   Eldeek, B S ^a   Tawhid, Z M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HLA A ANTIGEN; HLA B ANTIGEN;

ADULT; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DISEASE ACTIVITY; EGYPT; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS RESISTANCE;

ALANINE TRANSAMINASE; CASE-CONTROL STUDIES; EGYPT; HEPATITIS C, CHRONIC; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; LIVER CIRRHOSIS; VIRAL LOAD;

EID: 78149261909     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02468.x     Document Type: Article

References (42)

1. World Health Organization. Hepatitis C. Wkly Epidemiol Rec 1997;72:65-72.
2. World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec 1997;72:341-4.
3. Frank C, Mohamed MK, Strickland GT et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-91.
4. Abdel-Aziz F, Habib M, Mohamed MK et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000;32:111-5.
5. El-Sadawy M, Ragab H, El-Toukhy H et al. Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors. J Egypt Soc Parasitol 2004;34:367-84.
6. Nafeh MA, Medhat A, Shehata M et al. Hepatitis C in a community in upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 2000;63:236-41.
7. Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009;16:650-8.
8. El-Zanaty F, Way A. Egypt Demographic and Health Survey 2008. Cairo: Egyptian Ministry of Health, El-Zanaty and Associates, and Macro International, 2009:431.
9. Deuffic-Burban S, Mohamed MK, Larouze B, Carrat F, Valleron AJ. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 2006;44:455-61.
10. El-Chennawi FA, Auf FA, Metwally SS, Mosaad YM, El-Wahab MA, Tawhid ZE. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol Invest 2008;37:661-74.
11. Dore GJ, Freeman AJ, Law M, Kaldor JM. Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings. Antivir Ther 2003;8:365-72.
12. Wang JH, Zheng X, Ke X et al. Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virol J 2009;6:46.
13. Harris RA, Sugimoto K, Kaplan DE, Ikeda F, Kamoun M, Chang KM. Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans. Hepatology 2008;48:70-9.
14. McKiernan SM, Hagan R, Curry M et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004;40:108-14.
15. Scotto G, Fazio V, D'Alessandro G et al. Association between HLA class II antigens and hepatitis C virus infection. J Biol Regul Homeost Agents 2003;17:316-21.
16. Thio CL, Thomas DL, Goedert JJ et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001;184:16-21.
17. Zekri AR, El-Mahallawy HA, Hassan A, El-Din NH, Kamel AM. HLA alleles in Egyptian HCV genotype-4 carriers. Egypt J Immunol 2005;12:77-86.
18. Ishak K, Baptisa A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
19. Terasaki PI, Park MS. Microdroplet lymphocyte cytotoxicity test. In: Ray JG, ed. Manual of Tissue Typing Techniques. Bethesda: NIH, 1980:92-103, ISSN: 0147-7277.
20. Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007;13:1770-87.
21. Yoon SK, Han JY, Pyo CW et al. Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population. Liver Int 2005;25:1122-7.
22. Zavaglia C, Bortolon C, Ferrioli G et al. HLA typing in chronic type B, D and C hepatitis. J Hepatol 1996;24:658-65.
23. Lopez-Vazquez A, Rodrigo L, Mina-Blanco A et al. Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 2004;189:957-63.
24. Abdulghaffar A, Abas FA, Al Mobrak MF. The relationship between HLA typing and HCV infection and outcome of renal transplantation in HCV positive patients. Exp Clin Transplant 2003;1:19-25.
25. Fanning LJ, Kenny-Walsh E, Shanahan F. Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1. Hum Immunol 2004;65:745-51.
26. Tripathy AS, Shankarkumar U, Chadha MS, Ghosh K, Arankalle VA. Association of HLA alleles with hepatitis C infection in Maharashtra, western India. Indian J Med Res 2009;130:550-5.
27. Popov EA, Levitan BN, Alekseev LP, Pronina OA, Suchkov SV. Immunogenetic HLA markers of chronic viral hepatitis. Ter Arkh 2005;77:54-9.
28. Bondarenko AL, Baramzina SV. Role of HLA phenotype in the formation of chronic hepatitis C virus infection. Zh Mikrobiol Epidemiol Immunobiol 2002;2:55-7.
29. Thio CL, Gao X, Goedert JJ et al. HLA-Cw*04 and hepatitis C virus persistence. J Virol 2002;76:4792-7.
30. Kuzushita N, Hayashi N, Moribe T et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 1998;27:240-4.
31. Higashi Y, Kamikawaji N, Suko H, Ando M. Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C. J Gastroenterol Hepatol 1996;11:241-6.
32. Kondo Y, Kobayashi K, Kobayashi T et al. Distribution of the HLA class I allele in chronic hepatitis C and its association with serum ALT level in chronic hepatitis C. Tohoku J Exp Med 2003;201:109-17.
33. Neumann-Haefelin C, McKiernan S, Ward S et al. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 2006;43:563-72.
34. Chen DF, Endres W, Kliem V et al. No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease. Liver 1996;16:384-9.
35. Vitte RL, Fortier C, Richardet JP et al. HLA antigens in patients with chronic hepatitis C. Tissue Antigens 1995;45:356-61.
36. Verdon R, Pol S, Landais P et al. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients. J Hepatol 1994;21:388-93.
37. Peano G, Menardi G, Ponzetto A, Fenoglio LM. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 1994;154:2733-6.
38. McKiernan SM, Hagan R, Curry M et al. The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C. Gastroenterology 2000;118:1124-30.
39. Renou C, Halfon P, Pol S et al. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut 2002;51: 585-90.
40. Yu RB, Hong X, Ding WL et al. The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population. J Gastroenterol Hepatol 2008;23:1394-402. Epub 2007 Nov 19.
41. Patel K, Norris S, Lebeck L et al. HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. Hepatology 2006;43:241-9.
42. Wang LY, Lin HH, Lee TD et al. Human leukocyte antigen phenotypes and hepatitis C viral load. J Clin Virol 2005;32:144-50.